2YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| AP1867 | AP1867 | 195514-23-9 |
| SLF TFA | 2378802-47-0 | |
| FKBP12 PROTAC dTAG-7 | FKBP12 PROTAC DTAG-7 | 2064175-32-0 |
| AP1867-3-(aminoethoxy) | AP1867-3-(Methoxyethylamine) | 2127390-15-0 |
| KB02-SLF | KB02-SLF | 2384184-40-9 |
| Quiflapon sodium | 喹夫拉朋钠 | 147030-01-1 |
| AM103 | AM 103 | 1147872-22-7 |
| TAK-659 hydrochloride | TAK-659 (HYDROCHLORIDE) | 1952251-28-3 |
| MRX-2843 | UNC-2371A | 1429882-07-4 |
| TG101209 | N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 | 936091-14-4 |
| FLT3-IN-3 | SAN50900 | 2229050-90-0 |
| UNC2025 hydrochloride | UNC2025 盐酸盐 | 2070015-17-5 |
| Gilteritinib | 吉列替尼 | 1254053-43-4 |
| Gilteritinib hemifumarate | GILTERITINIB FUMARATE | 1254053-84-3 |
| FLT3-IN-6 | FLT3-IN-6 | 2377141-31-4 |
| Fostamatinib Disodium | R788(FOSTAMATINIB DISODIUM) | 1025687-58-4 |
| OTS447 | 化合物 OTS447 | 1356943-67-3 |
| ATH686 | 化合物ATH 686 | 853299-52-2 |
| 4SC-203 | 4SC-203 | 895533-09-2 |
| Fostamatinib | 福他替尼 | 901119-35-5 |
| Emavusertib | 4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- | 1801344-14-8 |
| Pacritinib | 帕克替尼 | 937272-79-2 |
| AG-09/1 | 2-[(6-methoxy-1H-benzimidazol-2-yl)thio]-N-(4-nitrophenyl)-acetamide | 356776-32-4 |
| HCH6-1 | D-Phenylalanine, N-benzoyl-L-tryptophyl-, methyl ester | 1435265-06-7 |
| FPR Agonist 43 | 1-(4-氯苯基)-3-(5-异丙基-1-甲基-3-氧亚基-2-苯基-2,3-二氢-1H-吡唑-4-基)脲 | 903895-98-7 |
| {Boc}-Phe-Leu-Phe-Leu-Phe | BOC-PHE-D-LEU-PHE-D-LEU-PHE-OH | 66556-73-8 |
| BMS-986235 | BMS-986235 | 2253947-47-4 |
| GPR120 Agonist 2 | 3-(4-((5-氯-2,2-二甲基-2,3-二氢苯并呋喃-7-基)甲氧基)-2,3-二甲基苯基)丙酸 | 1234844-11-1 |
| GPR40/FFAR1 modulator 1 | GPR40/FFAR1 modulator 1 | 874755-26-7 |
| TUG-1375 | (2R,4R)-2-(2-氯苯基)-3-(4-(3,5-二甲基异恶唑-4-基)苯甲酰)噻唑烷-4-甲酸 | 2247372-59-2 |
| AMG7703 | (S)-2-(4-chlorophenyl)-3-Methyl-N-(thiazol-2-yl)butanaMide | 1103523-24-5 |
| TUG-469 | TUG-469 | 1236109-67-3 |
| AM-4668 | AM-4668 | 1011531-27-3 |
| GPR40 Activator 2 | 化合物 T11457 | 1312787-30-6 |
| AM-1638 | 化合物 T14200 | 1142214-62-7 |
| GPR40 agonist 6 | 化合物 GPR40 AGONIST 6 | 1798751-25-3 |
| LY2922470 | LY2922470 | 1423018-12-5 |
| AH 7614 | AH 7614 | 6326-06-3 |
| Fezagepras sodium | 1254472-97-3 | 1254472-97-3 |
| TUG-770 | TUG-770 | 1402601-82-4 |
| TAK-875 | TAK-875 | 1000413-72-8 |
| FB23 | FB23 | 2243736-35-6 |
| PX20606 trans racemate | CPDD1220反式消旋体 | 1268244-85-4 |
| LY2562175 | 化合物LY2562175 | 1103500-20-4 |
| Cilofexor | CILOFEXOR; GS-9674; GS 9674; GS9674; | 1418274-28-8 |
| DY268 | DY 268 | 1609564-75-1 |
| Vidofludimus | 维多氟拉迪莫 | 717824-30-1 |
| Vonafexor | YP001 | 1192171-69-9 |
| Tropifexor | Tropifexor | 1383816-29-2 |
| HM43239 | 化合物HM43239 | 2294874-49-8 |
| Diflapolin | 双黄素 | 724453-98-9 |
| PP58 | Pyrido[2,3-d]pyrimidin-7(8H)-one,2-[[4-(2-aminoethoxy)phenyl]amino]-6-(2,6-dichlorophenyl)-8-methyl- | 212391-58-7 |
| Zoligratinib | DEBIO-1347 | 1265229-25-1 |
| Derazantinib | 德拉赞替尼 | 1234356-69-4 |
| Derazantinib Racemate | 化合物 T10997 | 2309668-44-6 |
| ASP5878 | ASP-5878 | 1453208-66-6 |
| Bemarituzumab | 贝马里妥珠单抗 | 1952272-74-0 |
| BO-264 | BO-264 | 2408648-20-2 |
| Ponatinib hydrochloride | 泊那替尼盐酸盐 | 1114544-31-8 |
| KW-2449 | [4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮 | 1000669-72-6 |
| S49076 | CS-2684 | 1265965-22-7 |
| TG 100572 Hydrochloride | 4-氯-3-[5-甲基-3-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-1,2,4-苯并三嗪-7-基]苯酚单盐酸盐 | 867331-64-4 |
| FGFR1/DDR2 inhibitor 1 | FGFR1/DDR2 inhibitor 1 | 2308497-58-5 |
| FIIN-3 | FIIN-3 | 1637735-84-2 |
| MAX-40279 hemifumarate | 化合物 MAX-40279 HEMIFUMARATE | 2388506-43-0 |
| MAX-40279 hemiadipate | 化合物 MAX-40279 HEMIADIPATE | 2388506-44-1 |
| Surfen dihydrochloride | 1,3-bis(4-amino-2-methyl-6-quinolyl)urea dihydrochloride | 5424-37-3 |
| SU4984 | CIVENTICHEM CV-409 | 186610-89-9 |
| ASN03576800 | ASN03576800 | 957513-35-8 |
| DSHS00884 | DSHS00884 | 675104-49-1 |
| EBOV/MARV-IN-1 | VUN65671 | 2479465-67-1 |
| 2'-Deoxy-5'-O-DMT-2'-fluorouridine | 5'-O-[双(4-甲氧基苯基)(苯基)甲基]-2'-脱氧-2'-氟尿苷 | 146954-74-7 |
| SAFit1 | SAFit1 | 1643125-32-9 |
| SLF-amido-C2-COOH | SLF-amido-C2-COOH | 1092369-24-8 |
| Shield-1 | 化合物SHIELD-1 | 914805-33-7 |
| AP1867-2-(carboxymethoxy) | FKBP12 LIGAND | 2230613-03-1 |
| FKBP12 PROTAC dTAG-13 | FKBP12 PROTAC DTAG-13 | 2064175-41-1 |
| PROTAC FLT-3 degrader 1 | PROTAC FLT-3 DEGRADER 1 | 2230826-81-8 |
| GW4064 | 3-(2,6-二氯苯基)-4-(3'-羧基-2-氯二苯乙烯-4-基)氧甲基-5-异丙基异恶唑 | 278779-30-9 |
| XL335 | 3-(3,4-二氟苯甲酰基)-1,2,3,6-四氢-1,1-二甲基氮杂卓[4,5-B]吲哚-5-甲酸 1-甲基乙基酯 | 629664-81-9 |
| TC-G 1005 | (4-环丙基-3,4-二氢-1(2H)-喹喔啉基)[4-(2,5-二甲基苯氧基)-3-吡啶基]甲酮 | 1415407-60-1 |
| SBI-115 | SBI-115 | 882366-16-7 |
| Triamterene | 氨苯蝶啶 | 396-01-0 |
| PEN (human) | PEN人源激动剂 | 597578-70-6 |
| Pipequaline | 哌夸林 | 77472-98-1 |
| MRK-016 | 342652-67-9 | 342652-67-9 |
| NEO 376 | 496921-73-4 | 496921-73-4 |
| CP-409092 hydrochloride | CP-409092 HYDROCHLORIDE | 225240-86-8 |
| TPA 023 | TPA 023 | 252977-51-8 |
| THIP | 加波沙朵 | 64603-91-4 |
| Zuranolone | CS-2797 | 1632051-40-1 |
| SSD114 hydrochloride | SSD114 HYDROCHLORIDE | 2319790-02-6 |
| Radequinil | RADEQUINIL | 219846-31-8 |
| RO 4938581 | RO4938581 | 883093-10-5 |
| Pivagabine | 匹伐加宾 | 69542-93-4 |
| Broflanilide | 溴虫氟苯双酰胺 | 1207727-04-5 |
| AZD7325 | 3-CinnolinecarboxaMide, 4-aMino-8-(2-fluoro-6-Methoxyphenyl)-N-propyl- | 942437-37-8 |
| ONO-8590580 | CS-2894 | 1802661-73-9 |
| Lotilaner | 洛替拉纳 | 1369852-71-0 |
| Alogabat | ALOGABAT | 2230009-48-8 |
联系方式
